相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Alteration of DBP Levels in CSF of Patients with MS by Proteomics Analysis
Zhaoyu Qin et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2009)
The synergy of elemental and biomolecular mass spectrometry: new analytical strategies in life sciences
J. Sabine Becker et al.
CHEMICAL SOCIETY REVIEWS (2009)
Utility of mass spectrometry for proteome analysis: part II. Ion-activation methods, statistics, bioinformatics and annotation
Farid E. Ahmed
EXPERT REVIEW OF PROTEOMICS (2009)
Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis
Shilian Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases
Hayrettin Tumani et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2008)
Utility of mass spectrometry for proteome analysis: part I. Conceptual and experimental approaches
Farid E. Ahmed
EXPERT REVIEW OF PROTEOMICS (2008)
Proteome analysis of cerebrospinal fluid in amyotrophic lateral sclerosis (ALS)
Johannes Brettschneider et al.
NEUROCHEMICAL RESEARCH (2008)
Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease
Peter Brechlin et al.
PROTEOMICS (2008)
Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues
J. T-J Huang et al.
MOLECULAR PSYCHIATRY (2008)
Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment
Wojciech Rozek et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Sandip Ray et al.
NATURE MEDICINE (2007)
CSF Metabolic and Proteomic Profiles in Patients Prodromal for Psychosis
Jeffrey T. -J. Huang et al.
PLOS ONE (2007)
The minimum information about a proteomics experiment (MIAPE)
Chris F. Taylor et al.
NATURE BIOTECHNOLOGY (2007)
Cerebrospinal fluid proteome profile in multiple sclerosis
V. Lehmensiek et al.
MULTIPLE SCLEROSIS (2007)
Erythropoietin in cerebrospinal fluid:: Age-related reference values and relevance in neurological disease
Karin Widl et al.
NEUROCHEMICAL RESEARCH (2007)
Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients
T. Jin et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Proteome analysis of cerebrospinal fluid in Guillain-Barre syndrome (GBS)
V. Lehmensiek et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
A gel-based proteomic comparison of human cerebrospinal fluid between inflicted and non-inflicted pediatric traumatic brain injury
Wei-Min Gao et al.
JOURNAL OF NEUROTRAUMA (2007)
Proteome studies of CSF in AD patients
P Davidsson et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2006)
Guidelines for the next 10 years of proteomics
MR Wilkins et al.
PROTEOMICS (2006)
Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid
Y Hu et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases
J Brettschneider et al.
JOURNAL OF NEUROLOGY (2005)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
BRITISH JOURNAL OF CANCER (2005)
The development of the DIGE system: 2D fluorescence difference gel analysis technology
R Marouga et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2005)
Proteomics analysis of human cerebrospinal fluid
XL Yuan et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
Proteomics analysis of prefractionated human lumbar cerebrospinal fluid
XL Yuan et al.
PROTEOMICS (2005)
The ABC's (and XYZ's) of peptide sequencing
H Steen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Development of biomarkers in multiple sclerosis
B Bielekova et al.
BRAIN (2004)
All about DIGE: quantification technology for differential-display 2D-gel proteomics
KS Lilley et al.
EXPERT REVIEW OF PROTEOMICS (2004)
Proteomics for protein expression profiling in neuroscience
WM Freeman et al.
NEUROCHEMICAL RESEARCH (2004)
A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease
O Carrette et al.
PROTEOMICS (2003)
The STARD statement for reporting studies of diagnostic accuracy: Explanation and elaboration
PM Bossuyt et al.
CLINICAL CHEMISTRY (2003)
Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system
S Gharbi et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry
P Davidsson et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2002)
Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs
H Reiber et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2001)